Clinical Trial Update: Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating the safety and efficacy of THL-P in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• THL-P

Snippet

Sponsor: Taiwan THL Co.LTd. | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED